Tinnitus: Clinical Insights in Its Pathophysiology-A Perspective
- PMID: 38532055
- PMCID: PMC11150221
- DOI: 10.1007/s10162-024-00939-0
Tinnitus: Clinical Insights in Its Pathophysiology-A Perspective
Abstract
Tinnitus, the perception of sound without a corresponding external sound source, and tinnitus disorder, which is tinnitus with associated suffering, present a multifaceted clinical challenge due to its heterogeneity and its incompletely understood pathophysiology and especially due to the limited therapeutic options. In this narrative review, we give an overview on various clinical aspects of tinnitus including its heterogeneity, contributing factors, comorbidities and therapeutic pathways with a specific emphasis on the implications for its pathophysiology and future research directions. Tinnitus exhibits high perceptual variability between affected individuals (heterogeneity) and within affected individuals (temporal variability). Hearing loss emerges as predominant risk factor and the perceived pitch corresponds to areas of hearing loss, supporting the compensatory response theory. Whereas most people who have tinnitus can live a normal life, in 10-20% tinnitus interferes severely with quality of life. These patients suffer frequently from comorbidities such as anxiety, depression or insomnia, acting as both risk factors and consequences. Accordingly, neuroimaging studies demonstrate shared brain networks between tinnitus and stress-related disorders shedding light on the intricate interplay of mental health and tinnitus. The challenge lies in deciphering causative relationships and shared pathophysiological mechanisms. Stress, external sounds, time of day, head movements, distraction, and sleep quality can impact tinnitus perception. Understanding these factors provides insights into the interplay with autonomic, sensory, motor, and cognitive processes. Counselling and cognitive-behavioural therapy demonstrate efficacy in reducing suffering, supporting the involvement of stress and anxiety-related networks. Hearing improvement, especially through cochlear implants, reduces tinnitus and thus indirectly validates the compensatory nature of tinnitus. Brain stimulation techniques can modulate the suffering of tinnitus, presumably by alteration of stress-related brain networks. Continued research is crucial for unravelling the complexities of tinnitus. Progress in management hinges on decoding diverse manifestations, identifying treatment-responsive subtypes, and advancing targeted therapeutic approaches.
Keywords: Aetiology; Comorbidity; Heterogeneity; Pathophysiology; Tinnitus; Treatment.
© 2024. The Author(s).
Conflict of interest statement
B. Langguth received honoraria for consultancy and speakers’ fees from ANM, AstraZeneca, Autifony Therapeutics, Decibel Therapeutics, Desyncra, Gerson Lehmanns Group, Lundbeck, Merz, MagVenture, Medical Tribune, Neurolite, Neuromod, Novartis, Pfizer, Rovi, Schwabe, Sea Pharma, Servier, Sonova and Sound Therapeutics; research funding from the Tinnitus Research Initiative, Bayhost, the German Research Foundation, the German Bundesministerium für Bildung und Forschung, the American Tinnitus Association, AstraZeneca, cerbomed, Neuromod and the European Union; funding for equipment from MagVenture and Deymed Diagnostic; and travel and accommodation payments from Eli Lilly, Lundbeck, Servier, and Pfizer. He owns shares of Sea Pharma. D. De Ridder received honoraria for consultancy and speakers’ fees from Abbott laboratories and research funding from ATA and TRI. W. Schlee received honoraria for consultancy and speakers’ fess from Schwabe, Pohl-Boskamp, and Pansatori. He received funding from the EU, the Bavarian Research Foundation, the German Research Foundation, Innosuisse, and the Rainwater Charitable Foundation. He is stakeholder of the Lenox uG and the HealthStudyClub GmbH, which aim to translate scientific knowledge into digital health applications. T. Kleinjung received honoraria for consultancy and speaker’s fees form Sonova and Schwabe and travel and accommodation payments from Cochlear. His research was funded from the Tinnitus Research Initiative, the Swiss National Science Foundation, the European Union, the Zurich Hearing Foundation and Cochlear.
Similar articles
-
Tinnitus: causes and clinical management.Lancet Neurol. 2013 Sep;12(9):920-930. doi: 10.1016/S1474-4422(13)70160-1. Lancet Neurol. 2013. PMID: 23948178 Review.
-
The Current State of Tinnitus Diagnosis and Treatment: a Multidisciplinary Expert Perspective.J Assoc Res Otolaryngol. 2024 Oct;25(5):413-425. doi: 10.1007/s10162-024-00960-3. Epub 2024 Aug 13. J Assoc Res Otolaryngol. 2024. PMID: 39138756 Free PMC article. Review.
-
Restoration of Deafferentation Reduces Tinnitus, Anxiety, and Depression: A Retrospective Study on Cochlear Implant Patients.Neural Plast. 2021 Jun 24;2021:6678863. doi: 10.1155/2021/6678863. eCollection 2021. Neural Plast. 2021. PMID: 34257641 Free PMC article.
-
Sound therapy (using amplification devices and/or sound generators) for tinnitus.Cochrane Database Syst Rev. 2018 Dec 27;12(12):CD013094. doi: 10.1002/14651858.CD013094.pub2. Cochrane Database Syst Rev. 2018. PMID: 30589445 Free PMC article.
-
Treatment of tinnitus.Curr Opin Otolaryngol Head Neck Surg. 2015 Oct;23(5):361-8. doi: 10.1097/MOO.0000000000000185. Curr Opin Otolaryngol Head Neck Surg. 2015. PMID: 26261868 Review.
Cited by
-
Efficacy of repetitive transcranial magnetic stimulation for subjective chronic tinnitus: a randomized controlled trial meta-analysis.Front Neurosci. 2025 Apr 15;19:1579846. doi: 10.3389/fnins.2025.1579846. eCollection 2025. Front Neurosci. 2025. PMID: 40303608 Free PMC article.
-
Sound-Evoked Neural Activity in Normal-Hearing Tinnitus: Effects of Frequency and Stimulated Ear Side.Brain Sci. 2024 May 27;14(6):544. doi: 10.3390/brainsci14060544. Brain Sci. 2024. PMID: 38928544 Free PMC article.
-
Tinnitus and Cognition in the Elderly: Unraveling the Impact of Symptom Burden on Cognitive Decline.Brain Sci. 2025 Aug 15;15(8):869. doi: 10.3390/brainsci15080869. Brain Sci. 2025. PMID: 40867200 Free PMC article.
-
The Medial Olivocochlear Efferent Pathway Potentiates Cochlear Amplification in Response to Hearing Loss.J Neurosci. 2025 Apr 9;45(15):e2103242025. doi: 10.1523/JNEUROSCI.2103-24.2025. J Neurosci. 2025. PMID: 39984203
-
The daily auditory environments of people with tinnitus.Sci Rep. 2025 Jul 30;15(1):27756. doi: 10.1038/s41598-025-10730-7. Sci Rep. 2025. PMID: 40738910 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical